More articles from commentary

You have access
Effects of gut microbiota on the brain: implications for psychiatry
Karen-Anne Neufeld and Jane A. Foster

J Psychiatry Neurosci May 01, 2009 34 (3) 230-231;
You have access
Glutamate and dopamine components in schizophrenia
Philip Seeman

J Psychiatry Neurosci March 01, 2009 34 (2) 143-149;
You have access
A new wave in the genetics of psychiatric disorders: the copy number variant tsunami
Ridha Joober and Patricia Boksa

J Psychiatry Neurosci January 01, 2009 34 (1) 55-59;
You have access
Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology
Debbie S. Moskowitz and Simon N. Young

J Psychiatry Neurosci January 01, 2006 31 (1) 13-20;
You have access
Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders
Mark D. Berry

J Psychiatry Neurosci September 01, 2004 29 (5) 337-345;
You have access
Anterior cingulate dysfunction: Implications for psychiatric disorders?
Murat Yücel, Stephen J. Wood, Alexander Fornito, Judith Riffkin, Dennis Velakoulis and Christos Pantelis

J Psychiatry Neurosci September 01, 2003 28 (5) 350-354;
You have access
The prodromal stage of psychotic illness: Observation, detection or intervention?
Jean Addington

J Psychiatry Neurosci March 01, 2003 28 (2) 93-97;
You have access
Drug-metabolizing cytochrome P450s in the brain
Sharon L. Miksys and Rachel F. Tyndale

J Psychiatry Neurosci November 01, 2002 27 (6) 406-415;
You have access
Evidence-based decisions about herbal products for treating mental disorders
David M. Gardner

J Psychiatry Neurosci September 01, 2002 27 (5) 324-333;
You have access
Neuroactive steroids and anxiety disorders
Jean-Michel Le Mellédo and Glen B. Baker

J Psychiatry Neurosci May 01, 2002 27 (3) 161-165;

Main menu

User menu

Search

More articles from commentary

Pages

Content

Authors & Reviewers

About